Johan M. Spoor does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FLUOROPHARMA MEDICAL, INC., MetaStat, Inc., AtheroNova Inc., AzurRx BioPharma, Inc., Perspective Therapeutics, Inc., and Protea Biosciences Group, Inc..

2014 was Johan M. Spoor's most active year for acquiring shares with 8 total transactions. Johan M. Spoor's most active month to acquire stocks was the month of November. 2017 was Johan M. Spoor's most active year for disposing of shares, totalling 1 transactions. Johan M. Spoor's most active month to dispose stocks was the month of October. 2024 saw Johan M. Spoor paying a total of $248,030.00 for 634,500 shares, this is the most they've acquired in one year. In 2017 Johan M. Spoor cashed out on 100,000 shares for a total of $0.00, their largest year based on trade value.